ScripGene-editing specialist Intellia Therapeutics, Inc. and cell manufacturing firm Cellex Inc said on 22 June that they are teaming up with the private equity group Blackstone Life Sciences to create
ScripRoche Pays $40m Up Front In Pact With Jnana Roche Holding AG agreed to pay $40m up front on 21 July under a partnership with Jnana Therapeutics Inc. centered on targeting solute carrier (SLC) prot